Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens

Journal of Controlled Release

Volumn 203, Issue , 2015, Pages 67-76

  Fehres, Cynthia M ^a   Kalay, Hakan ^a   Bruijns, Sven C M ^a   Musaafir, Sara A M ^a   Ambrosini, Martino ^a   Van Bloois, Louis ^b   Van Vliet, Sandra J ^a   Storm, Gert ^b,c   Garcia Vallejo, Juan J ^a   Van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Anti tumor vaccination; DC SIGN; Glycans; Human dendritic cells; Langerin; Liposomes

Indexed keywords

ANTIGENS; CELLS; CYTOLOGY; LIPOSOMES; MOBILE SECURITY; PEPTIDES; POLYSACCHARIDES; PROTEINS; T-CELLS; VACCINES;

ANTI-TUMORS; DC SIGNS; GLYCANS; HUMAN DENDRITIC CELLS; LANGERIN;

EPITOPES;

CD209 ANTIGEN; GLYCAN MODIFIED LIPOSOME; GLYCOPROTEIN GP 100; LANGERIN; LIPOSOME; MELAN A; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; ANTIGEN; CANCER VACCINE; CD207 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; GLYCOCONJUGATE; GLYCOSPHINGOLIPID; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; PEPTIDE; POLYSACCHARIDE; Y GLYCOLIPID;

ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHO CELL LINE; CONJUGATION; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LANGERHANS CELL; MOLECULAR SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; AMINO ACID SEQUENCE; CARBOHYDRATE ANALYSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, CD; CANCER VACCINES; CARBOHYDRATE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CROSS-PRIMING; DENDRITIC CELLS; DRUG DELIVERY SYSTEMS; GLYCOCONJUGATES; GLYCOSPHINGOLIPIDS; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; LIPOSOMES; MANNOSE-BINDING LECTINS; MOLECULAR SEQUENCE DATA; PEPTIDES; POLYSACCHARIDES; RECEPTORS, CELL SURFACE;

EID: 84923229925     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.040     Document Type: Article

References (48)

1. L.M. van den Berg, S.I. Gringhuis, and T.B. Geijtenbeek An evolutionary perspective on C-type lectins in infection and immunity Ann. N. Y. Acad. Sci. 1253 2012 149 158
2. Y. van Kooyk, and T.B. Geijtenbeek DC-SIGN: escape mechanism for pathogens Nat. Rev. Immunol. 3 2003 697 709
3. J. Valladeau, O. Ravel, C. zutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, C. Caux, S. Lebecque, and S. Saeland Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules Immunity 12 2000 71 81
4. N.E. Welty, C. Staley, N. Ghilardi, M.J. Sadowsky, B.Z. Igyarto, and D.H. Kaplan Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism J. Exp. Med. 210 2013 2011 2024
5. V. Bigley, N. McGovern, P. Milne, R. Dickinson, S. Pagan, S. Cookson, M. Haniffa, and M. Collin Langerin-expressing dendritic cells in human tissues are related to CD1c + dendritic cells and distinct from Langerhans cells and CD141high XCR1 + dendritic cells J. Leukoc. Biol. 2014
6. H. Tateno, K. Ohnishi, R. Yabe, N. Hayatsu, T. Sato, M. Takeya, H. Narimatsu, and J. Hirabayashi Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain J. Biol. Chem. 285 2010 6390 6400
7. B.J. Appelmelk, I. van Die, S.J. van Vliet, C.M. Vandenbroucke-Grauls, T.B. Geijtenbeek, and Y. van Kooyk Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells J. Immunol. 170 2003 1635 1639
8. M. Andreini, D. Doknic, I. Sutkeviciute, J.J. Reina, J. Duan, E. Chabrol, M. Thepaut, E. Moroni, F. Doro, L. Belvisi, J. Weiser, J. Rojo, F. Fieschi, and A. Bernardi Second generation of fucose-based DC-SIGN ligands: affinity improvement and specificity versus Langerin Org. Biomol. Chem. 9 2011 5778 5786
9. H. Feinberg, A.S. Powlesland, M.E. Taylor, and W.I. Weis Trimeric structure of langerin J. Biol. Chem. 285 2010 13285 13293
10. C.G. Figdor, Y. van Kooyk, and G.J. Adema C-type lectin receptors on dendritic cells and Langerhans cells Nat. Rev. Immunol. 2 2002 77 84
11. R. McDermott, U. Ziylan, D. Spehner, H. Bausinger, D. Lipsker, M. Mommaas, J.P. Cazenave, G. Raposo, B. Goud, S.H. de la, J. Salamero, and D. Hanau Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates Mol. Biol. Cell 13 2002 317 335
12. M. Thepaut, J. Valladeau, A. Nurisso, R. Kahn, B. Arnou, C. Vives, S. Saeland, C. Ebel, C. Monnier, C. zutter-Dambuyant, A. Imberty, and F. Fieschi Structural studies of langerin and Birbeck granule: a macromolecular organization model Biochemistry 48 2009 2684 2698
13. J. Idoyaga, A. Lubkin, C. Fiorese, M.H. Lahoud, I. Caminschi, Y. Huang, A. Rodriguez, B.E. Clausen, C.G. Park, C. Trumpfheller, and R.M. Steinman Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A Proc. Natl. Acad. Sci. U. S. A. 108 2011 2384 2389
14. J. Tel, S.P. Sittig, R.A. Blom, L.J. Cruz, G. Schreibelt, C.G. Figdor, and I. de Vries Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion J. Immunol. 191 2013 5005 5012
15. P.J. Tacken, W. Ginter, L. Berod, L.J. Cruz, B. Joosten, T. Sparwasser, C.G. Figdor, and A. Cambi Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation Blood 118 2011 4111 4119
16. A. Kretz-Rommel, F. Qin, N. Dakappagari, R. Torensma, S. Faas, D. Wu, and K.S. Bowdish In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models J. Immunother. 30 2007 715 726
17. P.J. Tacken, I. de Vries, K. Gijzen, B. Joosten, D. Wu, R.P. Rother, S.J. Faas, C.J. Punt, R. Torensma, G.J. Adema, and C.G. Figdor Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody Blood 106 2005 1278 1285
18. J. Idoyaga, C. Cheong, K. Suda, N. Suda, J.Y. Kim, H. Lee, C.G. Park, and R.M. Steinman Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo J. Immunol. 180 2008 3647 3650
19. S.K. Singh, I. Streng-Ouwehand, M. Litjens, H. Kalay, S. Burgdorf, E. Saeland, C. Kurts, W.W. Unger, and Y. van Kooyk Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization Eur. J. Immunol. 41 2011 916 925
20. S.K. Singh, J. Stephani, M. Schaefer, H. Kalay, J.J. Garcia-Vallejo, J. den Haan, E. Saeland, T. Sparwasser, and Y. van Kooyk Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation Mol. Immunol. 47 2009 164 174
21. W.W. Unger, and Y. van Kooyk 'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells Curr. Opin. Immunol. 23 2011 131 137
22. L.C. Bonifaz, D.P. Bonnyay, A. Charalambous, D.I. Darguste, S. Fujii, H. Soares, M.K. Brimnes, B. Moltedo, T.M. Moran, and R.M. Steinman In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination J. Exp. Med. 199 2004 815 824
23. T. Tsuji, J. Matsuzaki, M.P. Kelly, V. Ramakrishna, L. Vitale, L.Z. He, T. Keler, K. Odunsi, L.J. Old, G. Ritter, and S. Gnjatic Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8 + and CD4 + T cell responses with broad antigen specificity J. Immunol. 186 2011 1218 1227
24. R. Ribeiro-Viana, J.J. Garcia-Vallejo, D. Collado, E. Perez-Inestrosa, K. Bloem, Y. van Kooyk, and J. Rojo BODIPY-labeled DC-SIGN-targeting glycodendrons efficiently internalize and route to lysosomes in human dendritic cells Biomacromolecules 13 2012 3209 3219
25. W.W. Unger, A.J. van Beelen, S.C. Bruijns, M. Joshi, C.M. Fehres, L. van Bloois, M.I. Verstege, M. Ambrosini, H. Kalay, K. Nazmi, J.G. Bolscher, E. Hooijberg, T.D. de Gruijl, G. Storm, and Y. van Kooyk Glycan-modified liposomes boost CD4 + and CD8 + T-cell responses by targeting DC-SIGN on dendritic cells J. Control. Release 160 2012 88 95
26. L. de Witte, A. Nabatov, M. Pion, D. Fluitsma, M.A. de Jong, T. de Gruijl, V. Piguet, Y. van Kooyk, and T.B. Geijtenbeek Langerin is a natural barrier to HIV-1 transmission by Langerhans cells Nat. Med. 13 2007 367 371
27. M. van der Vlist, L. de Witte, R.D. de Vries, M. Litjens, M.A. de Jong, D. Fluitsma, R.L. de Swart, and T.B. Geijtenbeek Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4(+) T cells but are incapable of cross-presentation Eur. J. Immunol. 41 2011 2619 2631
28. M.A. de Jong, L.E. Vriend, B. Theelen, M.E. Taylor, D. Fluitsma, T. Boekhout, and T.B. Geijtenbeek C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi Mol. Immunol. 47 2010 1216 1225
29. K. Bloem, J.J. Garcia-Vallejo, I.M. Vuist, B.A. Cobb, S.J. van Vliet, and Y. van Kooyk Interaction of the capsular polysaccharide A from Bacteroides fragilis with DC-SIGN on human dendritic cells is necessary for its processing and presentation to T cells Front. Immunol. 4 2013 103
30. M.D. Joshi, W.W. Unger, A.J. van Beelen, S.C. Bruijns, M. Litjens, L. van Bloois, H. Kalay, Y. van Kooyk, and G. Storm DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations Int. J. Pharm. 416 2011 426 432
31. T.B. Geijtenbeek, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, G.J. Adema, Y. van Kooyk, and C.G. Figdor Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses Cell 100 2000 575 585
32. T.B. Geijtenbeek, G.C. van Duijnhoven, S.J. van Vliet, E. Krieger, G. Vriend, C.G. Figdor, and Y. van Kooyk Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1 J. Biol. Chem. 277 2002 11314 11320
33. E. Hooijberg, J.J. Ruizendaal, P.J. Snijders, E.W. Kueter, J.M. Walboomers, and H. Spits Immortalization of human CD8 + T cell clones by ectopic expression of telomerase reverse transcriptase J. Immunol. 165 2000 4239 4245
34. C.A. Aarnoudse, M. Bax, M. Sanchez-Hernandez, J.J. Garcia-Vallejo, and Y. van Kooyk Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells Int. J. Cancer 122 2008 839 846
35. N. Schaft, R.A. Willemsen, J. de Vries, B. Lankiewicz, B.W. Essers, J.W. Gratama, C.G. Figdor, R.L. Bolhuis, R. Debets, and G.J. Adema Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes J. Immunol. 170 2003 2186 2194
36. A. Lanzavecchia, S. Abrignani, D. Scheidegger, R. Obrist, B. Dorken, and G. Moldenhauer Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets J. Exp. Med. 167 1988 345 352
37. C. Foged, C. Arigita, A. Sundblad, W. Jiskoot, G. Storm, and S. Frokjaer Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition Vaccine 22 2004 1903 1913
38. L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. Merkle, and E. Walter Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J. Control. Release 76 2001 59 71
39. S. Nierkens, J. Tel, E. Janssen, and G.J. Adema Antigen cross-presentation by dendritic cell subsets: one general or all sergeants? Trends Immunol. 34 2013 361 370
40. E. Bond, W.C. Adams, A. Smed-Sorensen, K.J. Sandgren, L. Perbeck, A. Hofmann, J. Andersson, and K. Lore Techniques for time-efficient isolation of human skin dendritic cell subsets and assessment of their antigen uptake capacity J. Immunol. Methods 348 2009 42 56
41. M. Yan, J. Peng, I.A. Jabbar, X. Liu, L. Filgueira, I.H. Frazer, and R. Thomas Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells Virology 324 2004 297 310
42. R.T. Lee, T.L. Hsu, S.K. Huang, S.L. Hsieh, C.H. Wong, and Y.C. Lee Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities Glycobiology 21 2011 512 520
43. A. Cambi, F. de Lange, N.M. van Maarseveen, M. Nijhuis, B. Joosten, E.M. van Dijk, B.I. de Bakker, J.A. Fransen, P.H. Bovee-Geurts, F.N. van Leeuwen, N.F. Van Hulst, and C.G. Figdor Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells J. Cell Biol. 164 2004 145 155
44. J.J. Garcia-Vallejo, and Y. van Kooyk The physiological role of DC-SIGN: a tale of mice and men Trends Immunol. 34 2013 482 486
45. A.M. van der Aar, D.I. Picavet, F.J. Muller, L. de Boer, T.M. van Capel, S.A. Zaat, J.D. Bos, H. Janssen, T.C. George, M.L. Kapsenberg, S.M. van Ham, M.B. Teunissen, and E.C. de Jong Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells J. Investig. Dermatol. 133 2013 1240 1249
46. A.M. van der Aar, R.M. Sylva-Steenland, J.D. Bos, M.L. Kapsenberg, E.C. de Jong, and M.B. Teunissen Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition J. Immunol. 178 2007 1986 1990
47. V. Flacher, M. Bouschbacher, E. Verronese, C. Massacrier, V. Sisirak, O. Berthier-Vergnes, B. de Saint-Vis, C. Caux, C. zutter-Dambuyant, S. Lebecque, and J. Valladeau Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria J. Immunol. 177 2006 7959 7967
48. L. Filgueira, F.O. Nestle, M. Rittig, H.I. Joller, and P. Groscurth Human dendritic cells phagocytose and process Borrelia burgdorferi J. Immunol. 157 1996 2998 3005